Winning entries will receive product kits free of charge and/or monetary grant to assist with the additional expenses to support the proposed project.
> Read More
Enzo Research Travel Grant is available for scientists who are presenting their work featuring Enzo’s products at research conferences and meetings.
> Read More
Clinical Associate Professor
Aquatic, Amphibian, and Reptile Pathology Program
Department of Comparative, Diagnostic, and Population Medicine, College of Veterinary Medicine, University of Florida
Gainesville, FL 32608
To determine localization of viral nucleic acid in the brain tissue and spinal cord lesions, Dr. Ossiboff is using AMPIVIEW™ Chuvirus (S) RNA probes to complete the characterization of the novel chuvirus that affect free ranging crocodilians associated with a neurologic disease.
I am a board certified veterinary anatomic pathologist, virologist, and molecular diagnostician with a primary professional focus on increasing the breadth and depth of knowledge of diseases of wildlife with special emphasis on reptiles and amphibians. Through a combined understanding of the fundamentals of disease pathogenesis, pathogen biology, disease pathology, and molecular/cellular biology, I approach animal disease investigations from multiple angles in an attempt to completely characterize disease conditions. My ultimate goal is to broadly impact the health of both captive and free-ranging wildlife through pathogen research and discovery, the creation and distribution of novel reagents, and the dissemination of knowledge
Research Assistant Professor
College of Pharmacy, Texas A&M University
Reynolds Medical Building, College Station, TX 77843
At AACR, my research using a unique inhibitor of Androgen receptor, will provide 1) mechanistic insight into treatment landscape of CRPC that will help develop novel inhibitors targeting the “Achilles Heel” of AR activity: the N-terminal domain 2) discern the role of the novel ubiquitination site in AR protein degradation through lysosomal pathway.
I am a Research Assistant Professor at Texas A&M University. The long-term goal of my research is to understand the molecular basis underlying carcinogenesis, progression, and drug resistance, and to bridge the gap between vast cancer transcriptome/proteome information and unmet clinical need. A major focus of my research is to understand specific target molecules through system biology approach to identify rewired cell signaling network as well as vulnerabilities and exploit them for developing treatment for metastatic carcinomas including Castration Resistant Prostate Cancer (CRPC), Muscle Invasive Bladder Cancer (MIBC) and Colorectal cancers (CRC). My work on metastatic carcinomas has been recognized at national as well as international level with awards such as AACR-CSCO (American Association for Cancer Research and Chinese Society of Clinical Oncology 2018/2019) young investigator award, Travel Awards at TiCER (Texas A&M Center for Environmental Health Research 2021) and END2Cancer, Oklahoma.
